AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,019 | -2.7% | 916 | 0.0% | 0.00% | – |
Q2 2023 | $65,824 | +128966.7% | 916 | +10.9% | 0.00% | – |
Q1 2023 | $51 | -20.3% | 826 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $64 | -99.8% | 826 | 0.0% | 0.00% | – |
Q3 2022 | $37,000 | +8.8% | 826 | -7.0% | 0.00% | – |
Q2 2022 | $34,000 | +183.3% | 888 | +208.3% | 0.00% | – |
Q1 2022 | $12,000 | -78.9% | 288 | -86.1% | 0.00% | – |
Q4 2021 | $57,000 | +256.2% | 2,078 | +324.1% | 0.00% | – |
Q3 2021 | $16,000 | -91.1% | 490 | -81.7% | 0.00% | -100.0% |
Q2 2021 | $180,000 | +9.1% | 2,671 | -8.6% | 0.00% | 0.0% |
Q1 2021 | $165,000 | -30.7% | 2,921 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $238,000 | +95.1% | 2,921 | +70.3% | 0.00% | +100.0% |
Q3 2020 | $122,000 | -41.1% | 1,715 | -31.7% | 0.00% | -50.0% |
Q2 2020 | $207,000 | +1492.3% | 2,512 | +1041.8% | 0.00% | – |
Q1 2020 | $13,000 | -58.1% | 220 | -26.7% | 0.00% | – |
Q4 2019 | $31,000 | +416.7% | 300 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |